NCT04068896 2025-05-29Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination TherapyNGM Biopharmaceuticals, IncPhase 1/2 Completed89 enrolled 21 charts
NCT00583349 2025-02-17Intravesicular Abraxane for Treatment-Refractory Bladder CancerColumbia UniversityPhase 1/2 Completed46 enrolled 11 charts
NCT01478685 2019-11-12A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid TumorsCelgenePhase 1 Completed169 enrolled
NCT00585689 2015-11-30Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder CancerUniversity of Michigan Rogel Cancer CenterPhase 2 Completed29 enrolled 11 charts
NCT00313599 2014-07-02Lapatinib and Paclitaxel in Treating Patients With Advanced Solid TumorsUniversity of California, San FranciscoPhase 1 Completed28 enrolled